Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Genitourinary 2Lymphoid 1

Conditions

Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteoporosis 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Spinal Cord Compression 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Osteonecrosis 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Bone Diseases, Metabolic 1

Interventions

Vitamin D 2Zoledronic Acid 1Risedronic Acid 1Calcium Carbonate 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Diseases, Metabolic × Zoledronic Acid × Lymphoid × Clear all
NCT00352846 2013-07-02

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
135 enrolled 4 charts
Lymphoid

Bone Diseases, Metabolic, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡